Correction: Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice.
Where this comes from
- Record sourced from PubMed, PMID 33326477.
- Also identified by DOI 10.1371/journal.pone.0244353 and PMC identifier 7743950.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0218494.].